Halve the PBS co-payment for biosimilars: GBMA

Sheshtyn Paola 20/02/2025

Reducing out-of-pocket costs and strengthening biosimilar uptake will deliver savings for people struggling with cost of living, says leading association The Generic and Biosimilar Medicines Association (GBMA) has proposed three policy reforms it says will improve health outcomes and provide cost-of-living relief for the three million Australians currently being prescribed biologics or biosimilars. In its

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

This web site is intended for Australian pharmacy professionals and is not a substitute for independent professional advice. Information and interactions contained in this website are for information purposes only and are not intended to be used to diagnose, treat, cure or prevent any disease. Further the accuracy, currency and completeness of the information available on this web site cannot be guaranteed. APPco Pty Ltd, its affiliates and their respective servants and agents do not accept any liability for any injury, loss or damage incurred by use of or reliance on the information made available via or through ajp.com.au whether arising from negligence or otherwise.

Halve the PBS co-payment for biosimilars: GBMA

Previous Wholesale costs offset Priceline growth

Next Different roles lifting the profession: Sim

MENU

ajp.com.au

Previous Wholesale costs offset Priceline growth

Next Different roles lifting the profession: Sim

MENU

ajp.com.au

Tags

Hi there! 👋 Looks like you’re not logged in.